Systemic Lupus Erythematosus

Researchers analyzed mortality statistics from the CDC to determine the relative burden of SLE-related deaths among women.

Ground-breaking trials presented at the 2018 European Lupus Society meeting demonstrate that inexpensive office-based tools can predict impending cardiovascular disease in patients with lupus.

For better or worse, social media and the Internet have a large role in the lives of young people-and as such are an effective way to reach them.

Highlights of the first UK guidelines on the care of adults with systemic lupus erythematosus.

However, researchers found that a common treatment for SLE reduces the risk of flares to that of non-pregnant women with lupus.

Consider screening for systemic lupus erythematosus in young patients who exhibit an escalating pattern of health care utilization.

Are you prepared to recognize and treat anxiety, depression, and other comorbid psychiatric disorders when they arise in your patients?

An online tool for juvenile arthritis, guidelines on childhood lupus, and good news about the response to treatment for ANCA-associated vasculitis

Be vigilant for the development of type 2 diabetes in patients with systemic lupus erythematosus.

Among the culprits: sunlight, cigarettes, and oral contraceptives.

What underlies the disparity in life expectancy between men and women with SLE?

The goal: to find a treatment target that protects against damage accrual in the early stages of SLE.

Obese patients report higher disease activity, more depressive symptoms, and greater pain and fatigue.

Up-to-date guidelines were developed to help improve patient outcomes.

Study findings highlight the need for physicians to heed the symptoms of testosterone deficiency.

LFA-REAL offers a straight-forward evaluation for lupus-affected organ systems, a study shows.

For systemic lupus erythematosus patients prescribed glucocorticosteroids, mortality has been found to be more frequent than in patients not prescribed glucocorticosteroids, researchers say.

There are few tests to accurately assess the degree and effects of lupus in children, but Ped-ANAM proves to be a promising option.

Lupus patients who receive healthcare at more than one location face a greater risk of infection and comorbidities, research shows.

Diagnosed with systemic lupus erythematosus and chikungunya, a woman embarks on a cross-continent trip for treatment and diagnosis at a city hospital.

Cryptococcal meningitis infections in systemic lupus erythematosus (SLE) patients often go misdiagnosed, researchers find.

Age and cumulative glucocorticoid exposure are key risk factors for low bone mineral density in systemic lupus erythematosus.

For high risk patients with systemic lupus erythematosus, teriparatide and denosumab may be an option for patients who have failed bisphosphonates. Here are some key points you need to know.

Bone loss could affect as many as 31 percent of SLE patients. This article sums up the treatment options from first-line bisphosphonate recommendations to emerging treatments like abaloparatide.

In this Q&A, Rheumatology Network speaks with Dr. Barbara Vilen who is making strides in both basic and translational research that may lead to new therapeutic targets for lupus.